Arkolith/Insider Trading/VRDN/Form 4

Meisner Lara

General Counsel and SecretaryViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Jan 25, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$244K
Net Open-Market Flow
-$244K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 23, 2023Option exercise(M)5K$23.03$114K5K
Jan 23, 2023Sell(S)7K$35.66$244K0
Jan 23, 2023Option exercise(M)2K$14.00$26K7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 23, 2023Option exercise(M)2K—$020K
Jan 23, 2023Option exercise(M)5K—$040K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-002674) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML